Suchergebnisse - "Anderson, Larry D"

PubPharm (92)

1

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

2

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

3

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

enthalten in: Blood cancer journal | 2024

von Afrough, A. | Hashmi, H. | Hansen, D. | +27

4

Transferring care to enhance access to early-phase cancer clinical trials : Protocol to evaluate a novel program

enthalten in: Contemporary clinical trials communications | 2024

von Nwachukwu, C. | Makhnoon, S. | Person, M. | +13

5

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma : a real-world analysis

enthalten in: Blood cancer journal | 2024

von Hoff, F. | Banerjee, R. | Khan, A. | +8

6

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

7

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma : A Real-World Experience

enthalten in: Transplantation and cellular therapy | 2024

von Dima, D. | Davis, J. | Ahmed, N. | +16

8

A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-up

enthalten in: EJHaem | 2024

von Anderson, L. | Bladé, J. | Kyle, R.

9

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting : An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

enthalten in: Transplantation and cellular therapy | 2024

von Oluwole, O. | Dholaria, B. | Knight, T. | +12

10

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2024

von Kumar, S. | Callander, N. | Adekola, K. | +33

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]